Skip to main content
Top
Published in: Malaria Journal 1/2011

Open Access 01-12-2011 | Reviews

Traditional medicines as a mechanism for driving research innovation in Africa

Authors: Ivan Addae-Mensah, Foluke Fakorede, Andreas Holtel, Solomon Nwaka

Published in: Malaria Journal | Special Issue 1/2011

Login to get access

Abstract

The outcomes from recent high profile deliberations concerning African health research and economic development all point towards the need for a mechanism to support health innovation on the continent. The mission of the African Network for Drugs and Diagnostics Innovation (ANDI), is to promote and sustain African-led health product innovation to address African public health needs through the assembly of research networks, and building of capacity to support human and economic development. ANDI is widely viewed as the vehicle to implementing some of these recommendations. There is tremendous opportunity for Africa, to leverage the expertise in natural products and traditional medicines in support of this objective to kick-start innovation. This report highlights key recommendations that have emerged through expert forums convened by ANDI on the challenges, opportunities and prospects for investing in this important area of research.
Literature
3.
go back to reference Nwaka S, Hudson A: Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006, 5: 941-55. 10.1038/nrd2144.CrossRefPubMed Nwaka S, Hudson A: Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006, 5: 941-55. 10.1038/nrd2144.CrossRefPubMed
5.
go back to reference Traditional Medicine - Growing Needs and Potential. WHO Policy Perspectives on Medicines. 2002, World Health Organization, Geneva, 2- Traditional Medicine - Growing Needs and Potential. WHO Policy Perspectives on Medicines. 2002, World Health Organization, Geneva, 2-
6.
go back to reference Wambebe CO, Bamgboye EA, Badru BO, Khamofu H, Momoh JA, Ekpeyong M, Audu BS, Njoku SO, Nasipuri NR, Kunle OO, Okogun JI, Enwerem NM, Gamaniel SK, Obodozie OO, Samuel B, Fojule G, Ogunyale PO: Efficacy of niprisan in the prophylactic management of patients with sickle cell disease. Curr Ther Res. 2001, 62: 26-34. 10.1016/S0011-393X(01)80039-4.CrossRef Wambebe CO, Bamgboye EA, Badru BO, Khamofu H, Momoh JA, Ekpeyong M, Audu BS, Njoku SO, Nasipuri NR, Kunle OO, Okogun JI, Enwerem NM, Gamaniel SK, Obodozie OO, Samuel B, Fojule G, Ogunyale PO: Efficacy of niprisan in the prophylactic management of patients with sickle cell disease. Curr Ther Res. 2001, 62: 26-34. 10.1016/S0011-393X(01)80039-4.CrossRef
7.
go back to reference Nwaka S, Ilunga T, Santos Da Silva J, Rial Verde E, Hackley D, De Vré R, Mboya-Okeyo T, Ridley RG: Developing ANDI: A Novel Approach to Health Product R&D in Africa. PLoS Med. 2010, 7: e100293-10.1371/journal.pmed.1000293.CrossRef Nwaka S, Ilunga T, Santos Da Silva J, Rial Verde E, Hackley D, De Vré R, Mboya-Okeyo T, Ridley RG: Developing ANDI: A Novel Approach to Health Product R&D in Africa. PLoS Med. 2010, 7: e100293-10.1371/journal.pmed.1000293.CrossRef
8.
go back to reference Mboya-Okeyo T, Ridley RG, Nwaka S: The African Network for Drugs and Diagnostics Innovation. Lancet. 2009, 373: 1507-1508. 10.1016/S0140-6736(09)60838-2.CrossRefPubMed Mboya-Okeyo T, Ridley RG, Nwaka S: The African Network for Drugs and Diagnostics Innovation. Lancet. 2009, 373: 1507-1508. 10.1016/S0140-6736(09)60838-2.CrossRefPubMed
Metadata
Title
Traditional medicines as a mechanism for driving research innovation in Africa
Authors
Ivan Addae-Mensah
Foluke Fakorede
Andreas Holtel
Solomon Nwaka
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2011
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-10-S1-S9

Other articles of this Special Issue 1/2011

Malaria Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine